Half a year after being spurned by the FDA and following deep layoffs, IO Biotech has decided to close its doors for good.

While its growth was overshadowed in 2025 by A.I., the biotech sector grew signifcantly and 2026 looks for the trend to ...

The six companies that have priced initial public offerings so far banked a median of $287.5 million, a figure far surpassing ...

U.S. venture capital firms are no longer waiting for Chinese biotech assets to surface before investing in them — they’re ...

Shares of IO Biotech, Inc. IOBT are plummeting Tuesday after the company announced it filed for Chapter 7 bankruptcy and will ...

Adaptive Biotechnologies, a leader in immune-driven diagnostics, reported a notable insider sale amid strong one-year stock ...

PSC Biotech partners with Blue Ocean Robotics to distribute the UVD Robot Pharma delivering autonomous UV C disinfection for GMP cleanroom environments. Purpose built for GMP cleanroom environments, ...

Legend Biotech Corporation (NASDAQ:LEGN) is one of the best high growth healthcare stocks to buy now. RBC Capital cut the price target on Legend Biotech Corporation (NASDAQ:LEGN) to $62 from $66 on ...

CNBC's Angelica Peebles reports the latest news surrounding Big Pharma.

Discover the Latest in Research Peptides at Biotech Labz Supply Sebastopol, United States - January 3, 2026 / Biotech ...

This little-known biotech could have a big hit on its hands with VK2735, a GLP-1 weight loss drug candidate.

View Legend Biotech Corp. Sponsored ADR LEGN stock quote prices, financial information, real-time forecasts, and company news from CNN.